Retinopathy of prematurity (ROP) is a vasoproliferative retinal disorder. Although its clinical presentation, classification, and treatment has been known in detail for several years, ROP remains as one of the leading causes of treatable childhood blindness worldwide, mainly in middle-income countries. Understanding ROPs epidemiology, pathophysiology, and risk factors enables better timely screening, monitoring, and treatment. ROP is a complex disease, which needs a multidisciplinary team to ensure appropriate care and management.
CITATION STYLE
Neves, L. M., & Zin, A. (2021). Retinopathy of prematurity. In Perinatology: Evidence-Based Best Practices in Perinatal Medicine (pp. 1189–1213). Springer International Publishing. https://doi.org/10.1007/978-3-030-83434-0_63
Mendeley helps you to discover research relevant for your work.